The store will not work correctly when cookies are disabled.
2-(5,6-dichloro-1H-benzo[d][1,2,3]triazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
ID: ALA3735908
PubChem CID: 275783
Max Phase: Preclinical
Molecular Formula: C11H11Cl2N3O4
Molecular Weight: 320.13
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: OCC1OC(n2nnc3cc(Cl)c(Cl)cc32)C(O)C1O
Standard InChI: InChI=1S/C11H11Cl2N3O4/c12-4-1-6-7(2-5(4)13)16(15-14-6)11-10(19)9(18)8(3-17)20-11/h1-2,8-11,17-19H,3H2
Standard InChI Key: XUIJNCCBICNURA-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3560 1.3452 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-3.3560 -1.3452 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2071 -3.7498 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9971 -5.0249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4539 -4.6676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5643 -3.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5805 -2.5334 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3702 -5.4425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4277 -6.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2385 -6.5715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 1 0
2 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
7 12 1 0
16 17 1 0
15 18 1 0
14 19 1 0
19 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 320.13 | Molecular Weight (Monoisotopic): 319.0127 | AlogP: 0.35 | #Rotatable Bonds: 2 |
Polar Surface Area: 100.63 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.42 | CX Basic pKa: 0.24 | CX LogP: 0.85 | CX LogD: 0.85 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.74 | Np Likeness Score: -0.05 |
References
1. Loddo R, Novelli F, Sparatore A, Tasso B, Tonelli M, Boido V, Sparatore F, Collu G, Delogu I, Giliberti G, La Colla P.. (2015) Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5., 23 (21): [PMID:26443549] [10.1016/j.bmc.2015.09.035] |